Emerging Biological Therapies on the Horizon for β-Thalassemia

Download this slideset for an expert-curated overview of emerging biological therapies for β-thalassemia, including review of the latest clinical data leading to the recent approval of the erythroid maturation agent luspatercept for transfusion-dependent disease.
Maria Domenica Cappellini, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.12 MB
Released: December 6, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Celgene Corporation

Related Content

In slides from Clinical Care Options (CCO), experts provide insights into later-line treatment strategies for myelofibrosis

person default Abdulraheem Yacoub, MD Released: December 9, 2022

Experts highlight key studies being presented at the 2022 ASH Annual Meeting in this commentary from Clinical Care Options (CCO)

Catherine M. Broome, MD John M. Burke, MD Corey Cutler, MD, MPH, FRCPC person default David Dingli, MD, PhD Amir T. Fathi, MD Shaji K. Kumar, MD Sagar Lonial, MD Peter Martin, MD Marshall Mazepa, MD Srdan Verstovsek, MD, PhD Eunice S. Wang, MD Allison Wheeler, MD, MSCI Amer Zeidan, MBBS, MPH Released: December 7, 2022

Enter characteristics of your patient with immune thrombocytopenia (ITP) into this online tool to see recommendations from 5 experts

Hanny Al-Samkari, MD Catherine M. Broome, MD Sandhya Ramanathan Panch, MD, MPH person default Kristin Ammon Shimano, MD Released: October 26, 2022

Dr Hanny Al-Samkari of Harvard Medical School and Massachusetts General Hospital reviews current and investigational treatments for ITP, from Clinical Care Options (CCO)

Hanny Al-Samkari, MD Released: October 18, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings